Amanda Baker
Neuroradiology · San Francisco, CANPI 1790198125
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $22,828 of the $31,984 with a category attached, or 71.4%. Route 92 Medical, Inc. accounts for 78.4% of it on its own, with 10 other manufacturers making up the rest. 2025 is the largest year on record at $28,148, more than ten times the $153 reported in 2020.
Across 125 payments — averaging $255.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Route 92 Medical, Inc.$25K
- Stryker$2K
- Penumbra, Inc.$2K
- Medtronic$941
- Imperative Care, Inc$720
- Microvention, Inc.$252
- plus $561 from 5 others
What the payments were for
- Consulting fees$22,82871%
- Travel & lodging$2,4328%
- Food & beverage$6,72421%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Route 92 Medical, Inc. | 7 | $25,078 |
| Stryker | 56 | $2,455 |
| Penumbra, Inc. | 16 | $1,976 |
| Medtronic(2 entities) | 20 | $941 |
| Imperative Care, Inc | 9 | $720 |
| Microvention, Inc. | 5 | $252 |
| Johnson & Johnson | 8 | $199 |
| Balt USA, LLC | 1 | $173 |
| Nevro Corp. | 1 | $128 |
| Integra Lifesciences Corporation | 1 | $45 |
| Chiesi USA, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Penumbra System$1,547
- ZOOM 88-T LARGE DISTAL PLATFORM$649
- Navien$243
- AUGMENT INJECTABLE$175
- EVOLVE$168
- NEUROFORM ATLAS$149
- WINGSPAN$149
- SURPASS EVOLVE$146
- SOFIA 6F-131CM STR$144
- TARGET$133
- TREVO$132
- AXS INFINITY LS$132
- AXS CATALYST 7$132
- AXS VECTA 71$132
- Pipeline$131
- Senza$128
How this compares
$31,984 in reported general payments places this provider in the 85th percentile of 154 neuroradiology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other neuroradiology in San Francisco
- Fabio SettecaseSan Francisco$758K
- Daniel CookeSan Francisco$63K
- Matthew AmansSan Francisco$51K
- Steven HettsSan Francisco$49K
- Peter ChangSan Francisco$28K
- Howard RowleySan Francisco$18K
- Salil SomanSan Francisco$7K
- Victoria VuongSan Francisco$3K
- Christopher DowdSan Francisco$3K
- Aaron BerezMountain View$24.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.